KA
GSK icon

Kovack Advisors’s GSK GSK Stock Holding History

Kovack Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-11
Closed -$16K – 224
2015
Q1 		$16K Buy
+11
New +$631 0.01% 170

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Kovack Advisors's GSK Position: Q2 2026 in Review

Kovack Advisors increased its GSK (GSK) stake by 5.9% in Q2 2026, buying an estimated $18.1K and bringing the position to 6,135 shares worth $317K. The position accounts for 0.02% of the portfolio, ranked #783.

Kovack Advisors first reported a position in GSK in Q1 2015 and has held it in 39 quarters since. The position peaked at $985K in Q3 2016. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Kovack Advisors held 6,135 shares of GSK worth $317K as of Q2 2026.
  • Kovack Advisors bought 342 GSK shares in Q2 2026, an estimated $18.1K.
  • GSK made up 0.02% of Kovack Advisors's portfolio in Q2 2026, its #783 holding.
  • Kovack Advisors first reported a position in GSK in Q1 2015 and has held it in 39 quarters since.
  • Kovack Advisors's GSK position peaked at $985K in Q3 2016.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.